Besicare Ophthalmic Suspension
Besifloxacin 0.6% Eye prep
0.6%
Healthcare Pharmaceuticals Ltd.
| Pack size | 5 ml drop |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 350.00 AED |
Indications
Besicare Ophthalmic Suspension is used for:
Bacterial Conjunctivitis
Adult Dose
Adults: Instill one drop in the affected eye(s) 3 times daily (4-12 hours apart) for7 days.
Child Dose
Children > 1 year: Instill one drop in the affected eye(s) 3 times daily (4-12 hours apart) for 7 days.
< 1 year: Safety & efficacy not established
Renal Dose
Administration
Contra Indications
This drug is contraindicated in patients with a history of hypersensitivity to Besifloxacin, to other Quinolones or to any of the components in this formulation.
Precautions
This drug is for topical ophthalmic use only and should not be injected subconjunctivally, nor should it be introduced directly into the anterior chamber of the eye.
As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy.
Growth of Resistant Organisms with Prolonged Use
To prevent contamination do not touch the tip of the dropper to eye, eyelid or any surface of the affected eye.
Patients should not wear contact lenses during the course of therapy with this drug.
Shake well before use.
Pregnancy-Lactation
Pregnancy
There are no available human data during pregnancy to inform any drug-associated risks; however, systemic exposure to besifloxacin from ocular administration is low; oral administration of besifloxacin to pregnant rats during organogenesis or during pre/postnatal period did not produce adverse embryofetal or offspring effects at clinically relevant systemic exposures
Lactation
There are no data on presence of drug in human milk, effects on breastfed infant, or on milk production; however, systemic exposure to besifloxacin following topical ocular administration is low, and it is not known whether measurable levels of besifloxacin would be present in maternal milk following topical ocular administration
The developmental and health benefits of breastfeeding should be considered, along with mother’s clinical need for therapy, and any potential adverse effects on breastfed infant from treatment
Interactions
Adverse Effects
Side effects of Besifloxacin 0.6% Eye prep :
1-10%
Blurred vision,Conjunctival redness,Eye irritation,Eye pain,Eye pruritus,Headache
Mechanism of Action
Bactericidal
Inhibits DNA-gyrase (a topoisomerase) in susceptible organisms, which in turn inhibits cell division.
Note
Besicare 0.6% Ophthalmic Suspension manufactured by Healthcare Pharmaceuticals Ltd.. Its generic name is Besifloxacin 0.6% Eye prep. Besicare is availble in Bangladesh.
Farmaco BD drug index information on Besicare Ophthalmic Suspension is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.